OurView Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: low, flat compounded GLP-1 pricing at any dose, with no membership fee
Price is where OurView Health scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
OurView Health is an online telehealth platform for weight loss, hormone therapy and wellness, with care from licensed providers through the Telegra network. Compounded semaglutide is $109/mo and tirzepatide $129/mo at any prescribed dose, or $99 and $119/mo on a 3-month prepay, with no membership or shipping fee. Medication is compounded by Boudreaux's New Drug Store, a 503A pharmacy in Louisiana. Service covers 46 states plus DC.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to OurView Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
OurView Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $109/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- 46 states + DC
- FDA status
- No FDA warning letter on record
How we scored OurView Health
Each dimension is scored algorithmically from OurView Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.5/10At $109/mo, OurView Health runs about 40% below the $182 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.3/10OurView Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.6/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
8.0/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
7.5/10OurView Health is available in 46 states plus DC: all but Arkansas, Connecticut, Hawaii, New Jersey.
Support10%
5.1/10OurView Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this OurView Health review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 46 states plus DC
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $109–$129/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with OurView Health
We walked OurView Health’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Choose semaglutide or tirzepatide on the Weight Loss page.
- 2On the product page, pick Month-to-Month or 3 Months in Full.
- 3Tap Start Monthly Semaglutide Plan, which opens the Telegra-hosted intake with a Let's Get Started screen.
- 4The next screen asks for your height and weight.
- Prices are shown up front: semaglutide $109/mo or $297 for 3 months; tirzepatide $129/mo or $357 for 3 months.
- The site says the price stays the same at every prescribed dose, with no membership or shipping fee.
- Your payment is authorized at checkout but only collected after a provider approves treatment.
- Its FAQ says a photo ID and selfie are required to confirm your identity.
- A published FAQ lists the states it serves and the four it doesn't.
OurView Health customer support
- Phone
- (573) 685-6155
GLP-1 medications OurView Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides OurView Health offers
Beyond GLP-1s, OurView Health also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$109/mo for a 30-day supply at any prescribed dose; no membership or shipping fee. Longer plan: 3-mo $99/mo ($297 upfront).
$129/mo for a 30-day supply at any prescribed dose; no membership or shipping fee. Longer plan: 3-mo $119/mo ($357 upfront).
Ready to get started?
Plans and promotions change often, so check OurView Health's current pricing and active discounts before you decide.
What we like
- Low flat pricing: compounded semaglutide $109/mo and tirzepatide $129/mo at any prescribed dose
- No membership fee and free shipping; a 3-month prepay drops the price to $99 or $119/mo
- Names its pharmacy (Boudreaux's New Drug Store, a Louisiana 503A) and provider network (Telegra)
- LegitScript seal on the site and a published list of states served
- No contracts; your card is only charged after a provider approves treatment
Watch-outs
- Not available in Arkansas, Connecticut, Hawaii or New Jersey
- Only 1-month or 3-month plans; the 3-month price is paid upfront
- All sales are final once medication ships
- The website is run by a marketing agency (Kickstart Social), and the operating company isn't named
- Terms set Georgia law but require arbitration in San Diego, California
Is OurView Health worth it?
The short version of what OurView Health offers is low, flat compounded GLP-1 pricing at any dose, with no membership fee. It runs $109/month at every dose, toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
Beyond the medication itself, OurView Health charges the same price at every dose. It also charges no membership fee and is LegitScript-certified.
How much OurView Health costs
Compounded semaglutide runs $109/month and compounded tirzepatide runs $129/month.
That puts OurView Health below the roughly $182 median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide), which is a cost advantage you can count on.
For a direct comparison, Eden runs semaglutide and tirzepatide from $99/month, so compare it with OurView Health before you commit.
Medications: what OurView Health prescribes
OurView Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who OurView Health is best for, and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost: $109/month is below the roughly $182 median we track across the category (each program's lowest listed ongoing monthly price).
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
OurView Health is available in 46 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
OurView Health earns its place on the shortlist mainly on price: at $109/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where OurView Health scores best in our breakdown.
Ready to start with OurView Health?
From $109/mo. See current pricing and start your free consultation.
OurView Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare OurView Health vs…
OurView Health scores7.4/10
Side-by-side pricing, medications and scores. Pick a matchup.
OurView Health vs Amazon One Medical
Amazon One Medical scores 8.5/10
OurView Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this OurView Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See OurView Health's current pricing
Plans from $109/mo. Start your free consultation to check eligibility and today's price.